Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ASTRAZENECA PHARMACEUTICALS LP
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-09-30 to 2023-03-31
Current total value of award: $1107968000
Description: SARS-COV-2 PRE-EXPOSURE PROPHYLACTIC AZD MODIFICATION TO CHANGE DISTRIBUTION.